title: The identification of chromosomal translocation, t(4;6)(q22;q15), in prostate cancer.
abstract: Our previous work identified a chromosomal translocation t(4;6) in prostate cancer cell lines and primary tumors. Using probes located on 4q22 and 6q15, the breakpoints identified in LNCaP cells, we performed fluorescence in situ hybridization analysis to detect this translocation in a large series of clinical localized prostate cancer samples treated conservatively. We found that t(4;6)(q22;q15) occurred in 78 of 667 cases (11.7%). The t(4;6)(q22;q15) was not independently associated with patient outcome. However, it occurs more frequently in high clinical T stage, high tumor volume specimens and in those with high baseline PSA (P=0.001, 0.001 and 0.01, respectively). The t(4;6)(q22;q15) occurred more frequently in samples with two or more TMPRSS2:ERG fusion genes caused by internal deletion than in samples without these genomic alterations, but this correlation is not statistically significant (P=0.0628). The potential role of this translocation in the development of human prostate cancer is discussed.
authors.affiliation: Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, UK.
authors.forename: L
authors.initials: L
authors.lastname: Shan
authors.forename: L
authors.initials: L
authors.lastname: Ambroisine
authors.forename: J
authors.initials: J
authors.lastname: Clark
authors.forename: R J
authors.initials: RJ
authors.lastname: Yáñez-Muñoz
authors.forename: G
authors.initials: G
authors.lastname: Fisher
authors.forename: S C
authors.initials: SC
authors.lastname: Kudahetti
authors.forename: J
authors.initials: J
authors.lastname: Yang
authors.forename: S
authors.initials: S
authors.lastname: Kia
authors.forename: X
authors.initials: X
authors.lastname: Mao
authors.forename: A
authors.initials: A
authors.lastname: Fletcher
authors.forename: P
authors.initials: P
authors.lastname: Flohr
authors.forename: S
authors.initials: S
authors.lastname: Edwards
authors.forename: G
authors.initials: G
authors.lastname: Attard
authors.forename: J
authors.initials: J
authors.lastname: De-Bono
authors.forename: B D
authors.initials: BD
authors.lastname: Young
authors.forename: C S
authors.initials: CS
authors.lastname: Foster
authors.forename: V
authors.initials: V
authors.lastname: Reuter
authors.forename: H
authors.initials: H
authors.lastname: Moller
authors.forename: T D
authors.initials: TD
authors.lastname: Oliver
authors.forename: D M
authors.initials: DM
authors.lastname: Berney
authors.forename: P
authors.initials: P
authors.lastname: Scardino
authors.forename: J
authors.initials: J
authors.lastname: Cuzick
authors.forename: C S
authors.initials: CS
authors.lastname: Cooper
authors.forename: Y-J
authors.initials: YJ
authors.lastname: Lu
mesh_terms: D002894:Chromosomes, Human, Pair 4 / Q000235:genetics*; D002896:Chromosomes, Human, Pair 6 / Q000235:genetics*; D042822:Genomic Instability; D006801:Humans; D017404:In Situ Hybridization, Fluorescence; D008297:Male; D015514:Oncogene Proteins, Fusion / Q000235:genetics; D011379:Prognosis; D011471:Prostatic Neoplasms / Q000235:genetics* / Q000473:pathology; D014178:Translocation, Genetic
chemical_list: D015514:Oncogene Proteins, Fusion; C515553:TMPRSS2-ERG fusion protein, human